col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


52 Ergebisse       Seite 1

 [1] 
Elsevier: The Lancet HIV
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2024―Jan―30 Trends in COVID-19 admissions and deaths among people living with HIV in South Africa: analysis of national surveillance data Waasila Jassat, Caroline Mudara, Lovelyn Ozougwu, Richard Welch, Tracy Arendse, Maureen Masha, et al. (+17)
2 [GO] 2024―Jan―30 Insights on COVID-19 mortality and HIV from South Africa Jessica E Justman, Tara F Abularrage
3 [GO] 2023―Dez―21 Two decades fighting two pandemics Munyaradzi Makoni
4 [GO] 2023―Jul―05 Addressing the HIV crisis in the Philippines during the COVID-19 pandemic Rowalt Alibudbud
5 [GO] 2023―Mrz―10 UK HIV transmission drops in the wake of COVID-19 Tony Kirby
6 [GO] 2022―Nov―10 Living with COVID-19 and preparing for future pandemics: revisiting lessons from the HIV pandemic Judith D Auerbach, Andrew D Forsyth, Calum Davey, James R Hargreaves
7 [GO] 2022―Okt―28 Innovations, adaptations, and accelerations in the delivery of HIV services during COVID-19 Eamonn Murphy, Meg Doherty, Wafaa El Sadr, Irum Zaidi, Adeeba Kamarazulman, Siobhan Crowley, et al. (+11)
8 [GO] 2022―Mai―10 A collision of pandemics: HIV and COVID-19 Charles Feldman, Jarrod Zamparini
9 [GO] 2022―Mai―10 Clinical features of, and risk factors for, severe or fatal COVID-19 among people living with HIV admitted to hospital: analysis of data from the WHO Global Clinical Platform of COVID-19 Silvia Bertagnolio, Soe Soe Thwin, Ronaldo Silva, Sairaman Nagarajan, Waasila Jassat, Robert Fowler, et al. (+5)
10 [GO] 2022―Apr―27 HIV and COVID-19: juxtaposition of two pandemics John Nkengasong
11 [GO] 2022―Apr―27 Immunogenicity and safety of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine in people living with and without HIV-1 infection: a randomised, controlled, phase 2A/2B trial Shabir A Madhi, Dhayendre Moodley, Sherika Hanley, Moherndran Archary, Zaheer Hoosain, Umesh Lalloo, et al. (+41)
12 [GO] 2022―Mrz―22 Can COVID-19 changes reduce stigma in African HIV clinics? Sarah M Lofgren, Joanita Kigozi, Nakita G Natala, Sharon Tsui, Anita Arinda, Vanessa Akinyange, et al. (+3)
13 [GO] 2021―Dez―08 COVID-19 antivirals must not affect HIV drug supply Melissa Barber, Ameet Sarpatwari, Christa Cepuch
14 [GO] 2021―Nov―01 Prioritise people with HIV for COVID-19 vaccination The Lancet HIV
15 [GO] 2021―Okt―15 Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study Daniel K Nomah, Juliana Reyes-Urueña, Yesika Díaz, Sergio Moreno, Jordi Aceiton, Andreu Bruguera, et al. (+95)
16 [GO] 2021―Okt―15 Associations between HIV infection and clinical spectrum of COVID-19: a population level analysis based on US National COVID Cohort Collaborative (N3C) data Xueying Yang, Jing Sun, Rena C Patel, Jiajia Zhang, Siyuan Guo, Qulu Zheng, et al. (+19)
17 [GO] 2021―Okt―14 More evidence for worse COVID-19 outcomes in people with HIV Marta Boffito, Laura Waters
18 [GO] 2021―Aug―17 Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial Shabir A Madhi, Anthonet L Koen, Alane Izu, Lee Fairlie, Clare L Cutland, Vicky Baillie, et al. (+32)
19 [GO] 2021―Aug―04 Epidemiology of severe COVID-19 from South Africa Shabir A Madhi, Jeremy Nel
20 [GO] 2021―Aug―04 Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort study Waasila Jassat, Cheryl Cohen, Stefano Tempia, Maureen Masha, Susan Goldstein, Tendesayi Kufa, et al. (+1567)
21 [GO] 2021―Aug―03 Young people with HIV struggle during another pandemic Christabel Ligami
22 [GO] 2021―Jun―18 Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial John Frater, Katie J Ewer, Ane Ogbe, Mathew Pace, Sandra Adele, Emily Adland, et al. (+63)
23 [GO] 2021―Jun―18 SARS-CoV-2 vaccination in people with HIV Matthew A Spinelli
24 [GO] 2021―Jun―03 COVID-19 shows need for UN General Assembly push to end AIDS Shannon Hader
25 [GO] 2021―Jun―01 Failure to seroconvert after two doses of BNT162b2 SARS-CoV-2 vaccine in a patient with uncontrolled HIV Emma Touizer, Aljawharah Alrubayyi, Chloe Rees-Spear, Natasha Fisher-Pearson, Sarah A Griffith, Luke Muir, et al. (+9)
26 [GO] 2021―Apr―30 SARS-CoV-2 immunity and HIV infection: total recall? Nicolas Dauby, Charlotte Martin
27 [GO] 2021―Apr―30 SARS-CoV-2 seroprevalence, and IgG concentration and pseudovirus neutralising antibody titres after infection, compared by HIV status: a matched case-control observational study Matthew A Spinelli, Kara L Lynch, Cassandra Yun, David V Glidden, Michael J Peluso, Timothy J Henrich, et al. (+2)
28 [GO] 2021―Apr―27 Overview of SARS-CoV-2 infection in adults living with HIV Juan Ambrosioni, José Luis Blanco, Juliana M Reyes-Urueña, Mary-Ann Davies, Omar Sued, Maria Angeles Marcos, et al. (+44)
29 [GO] 2021―Feb―21 The potential effect of COVID-19-related disruptions on HIV incidence and HIV-related mortality among men who have sex with men in the USA: a modelling study Kate M Mitchell, Dobromir Dimitrov, Romain Silhol, Lily Geidelberg, Mia Moore, Albert Liu, et al. (+4)
30 [GO] 2021―Feb―06 The impact of the COVID-19 lockdown on HIV care in 65 South African primary care clinics: an interrupted time series analysis Jienchi Dorward, Thokozani Khubone, Kelly Gate, Hope Ngobese, Yukteshwar Sookrajh, Siyabonga Mkhize, et al. (+7)
31 [GO] 2021―Feb―03 Brazil sustains HIV response during the COVID-19 pandemic Gerson F Mendes Pereira
32 [GO] 2021―Jan―23 Do not repeat mistakes from HIV in COVID-19 response The Lancet HIV
33 [GO] 2020―Dez―30 Maintaining ART services during COVID-19 border closures: lessons learned in Namibia Linea Hans, Steven Y Hong, Laimi S N Ashipala, Leonard Bikinesi, Ndapewa Hamunime, Jacques W N Kamangu, et al. (+2)
34 [GO] 2020―Dez―13 COVID-19 death in people with HIV: interpret cautiously Laura J Waters, Anton L Pozniak
35 [GO] 2020―Dez―13 HIV infection and COVID-19 death: a population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform Krishnan Bhaskaran, Christopher T Rentsch, Brian MacKenna, Anna Schultze, Amir Mehrkar, Chris J Bates, et al. (+19)
36 [GO] 2020―Dez―01 COVID-19 threatens HIV care continuity in Brazil Joe Parkin Daniels
37 [GO] 2020―Okt―08 Pandemics have psychosocial and sociocultural burdens Lisa McDaid, Paul Flowers
38 [GO] 2020―Aug―06 Modelling the impact of COVID-19 on HIV Maia Lesosky, Landon Myer
39 [GO] 2020―Aug―06 Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical models Britta L Jewell, Edinah Mudimu, John Stover, Debra ten Brink, Andrew N Phillips, Jennifer A Smith, et al. (+13)
40 [GO] 2020―Aug―04 Control of epidemics by jails: lessons for COVID-19 from HIV Tochi Ohuabunwa, Anne C Spaulding
41 [GO] 2020―Aug―03 PrEP retention and prescriptions for pregnant women during COVID-19 lockdown in South Africa Dvora L Joseph Davey, Linda-Gail Bekker, Nyiko Mashele, Pamina Gorbach, Thomas J Coates, Landon Myer
42 [GO] 2020―Jul―17 Postexposure prophylaxis during COVID-19 lockdown in Melbourne, Australia Eric P F Chow, Jane S Hocking, Jason J Ong, Tiffany R Phillips, Christopher K Fairley
43 [GO] 2020―Mai―28 Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort Pilar Vizcarra, María J Pérez-Elías, Carmen Quereda, Ana Moreno, María J Vivancos, Fernando Dronda, et al. (+31)
44 [GO] 2020―Mai―28 COVID-19 in people with HIV Zhe Xu, Chao Zhang, Fu-Sheng Wang
45 [GO] 2020―Mai―25 HIV postexposure prophylaxis during COVID-19 Muhammad Junejo, Nicolo Girometti, Alan McOwan, Gary Whitlock, Keerti Gedela, Nicolo Girometti, et al. (+7)
46 [GO] 2020―Mai―15 COVID-19 in patients with HIV Rachael Jones, Mark Nelson, Margherita Bracchi, David Asboe, Marta Boffito
47 [GO] 2020―Mai―15 COVID-19 in patients with HIV - Authors' reply José M Miró, Juan Ambrosioni, Jose L Blanco
48 [GO] 2020―Apr―24 When pandemics collide The Lancet HIV
49 [GO] 2020―Apr―15 COVID-19 in patients with HIV: clinical case series Jose L Blanco, Juan Ambrosioni, Felipe Garcia, Esteban Martínez, Alex Soriano, Josep Mallolas, Jose M Miro
50 [GO] 2020―Apr―13 Three lessons for the COVID-19 response from pandemic HIV James Hargreaves, Calum Davey, James Hargreaves, Calum Davey, Judith Auerbach, Jamie Blanchard, et al. (+24)
51 [GO] 2020―Apr―08 Tuberculosis and HIV responses threatened by COVID-19 Paul Adepoju
52 [GO] 2020―Apr―06 Maintaining HIV care during the COVID-19 pandemic Hongbo Jiang, Yi Zhou, Weiming Tang
 [1] 

52 Ergebisse       Seite 1



[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.003 sec